NCT05282082View on ClinicalTrials.gov

Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

UnknownOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

February 28, 2023

Study Completion Date

March 1, 2024

Conditions
Pseudomonas AeruginosaColonization, AsymptomaticNosocomial Infection
Trial Locations (3)

Unknown

RECRUITING

Dr Cipto Mangunkusumo General Hospital, Jakarta

NOT_YET_RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

3015 GD

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Dr Cipto Mangunkusumo General Hospital

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

lead

Erasmus Medical Center

OTHER